What should you know about CMV immunohistochemistry?

A pathologist examines the staining pattern together with the tissue's microscopic appearance. The test can support a diagnosis of CMV infection in the sampled area, but the result must be interpreted with symptoms, immune status, specimen quality, and any other CMV tests.

The laboratory applies antibodies designed to bind to CMV proteins in a prepared tissue section. A visible marker shows the pathologist where binding has occurred. The pathologist checks whether staining is located in cells with compatible changes and whether controls show that the test performed as expected.

A positive result indicates CMV material in cells within that specimen and may explain local inflammation or injury. A negative result means the stain did not identify CMV in the section examined; it cannot by itself exclude infection elsewhere or infection missed because affected cells were sparse. Additional tissue levels, molecular testing, or blood tests may sometimes help resolve uncertainty.

Review the pathology report with the clinician managing the illness. Ask which tissue was tested, whether CMV-positive cells were seen, how the surrounding tissue looked, and whether another CMV method was used. Treatment decisions also depend on the organ involved, symptom severity, immune function, and medicines that suppress immunity.

Continue prescribed medicines unless your clinical team changes them. Do not start, stop, or reduce antiviral or immune-suppressing treatment solely from a line on the report. If the specimen came from a recent biopsy, follow the procedure-specific instructions for dressing care, activity, food, and signs of bleeding or infection.

Seek urgent medical care for severe breathlessness, confusion, fainting, new weakness, a sudden change in vision, heavy gastrointestinal bleeding, or severe abdominal pain. Prompt assessment is also needed for fever with shaking chills in someone whose immune system is suppressed.

After a biopsy, use the emergency instructions supplied by the procedure team for bleeding that does not stop, breathing difficulty, or rapidly increasing pain or swelling. For worsening diarrhoea, persistent vomiting, trouble swallowing, or new visual disturbance, contact the treating team without waiting for a routine appointment.

Consider asking: Does this result show tissue-invasive CMV or only raise suspicion? Could sampling have missed affected cells? Which other test results support the interpretation? Clarify whether oncology or transplant medicines need adjustment, who will coordinate those decisions, and which symptoms should trigger same-day contact.